Oxybutynin Extended-Release Tablets and Von willebrand factor recombinant Intravenous
Determining the interaction of Oxybutynin Extended-Release Tablets and Von willebrand factor recombinant Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: oxybutynin
Brand name: Ditropan XL, Anturol, Gelnique, Oxytrol
Synonyms: Oxybutynin
Generic Name: von willebrand factor
Brand name: Vonvendi, Wilfactin
Synonyms: Von Willebrand factor (recombinant), von Willebrand Factor (Recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Oxybutynin Extended-Release Tablets-Vonvendi
- Oxybutynin Extended-Release Tablets-Vopac
- Oxybutynin Extended-Release Tablets-Vopac MDS
- Oxybutynin Extended-Release Tablets-Vorapaxar
- Oxybutynin Extended-Release Tablets-Vorapaxar Sulfate
- Oxybutynin Extended-Release Tablets-Voraxaze
- Von willebrand factor recombinant Intravenous-Oxybutynin Gel
- Von willebrand factor recombinant Intravenous-Oxybutynin Oral Solution
- Von willebrand factor recombinant Intravenous-Oxybutynin Syrup
- Von willebrand factor recombinant Intravenous-Oxybutynin Tablets
- Von willebrand factor recombinant Intravenous-Oxybutynin transdermal
- Von willebrand factor recombinant Intravenous-Oxybutynin Transdermal System